Amsterdam [Netherlands], November 10 (ANI/Sputnik): The European Medicines Agency (EMA) said on Wednesday that it had begun analyzing the use of Moderna's COVID-19 vaccine in children aged 6 to 11 years old.
Spikevax, Moderna’s COVID-19 vaccine received a recommendation for approval by the European drug regulator on Friday. We can now get children between the ages of 12 and 17 years to take the shot. It is now the second COVID-19 vaccine to get authorization for children. Here’s everything about it. What is the Moderna Spikevax? This […]
\
\
\
\
